StockUS listing USABTNYSEHealthcareDefensive Anchor

Abbott Laboratories(ABT) Stock Analysis | Healthcare

USD --+0.00%
Reward48Moderate
Risk19Low
75%Data
2.5% dividend yield · Revenue growing 13% YoY
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 172.35Bn
Reward Ratingⓘ48 Moderate reward assessment · 75% data coverage
Bottom 25% of stocksView factors
Risk Ratingⓘ19 Low risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on ABT to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Abbott Laboratories?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.

AI Brief Pro

The brief on Abbott Laboratories

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Abbott Laboratories?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 172.35B, and a P/E ratio of 32.1x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (48)

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Devices
Market Cap172.35B
P/E Ratio32.129
Beta0.583
Insider Activity
12M windowMixed
Shares soldShares bought
0-3months
0
0
3-6months
0
0
6-9months
53,055 shares
$353k
110,000 shares
$1.1M
9-12months
0
0

Openbook research

Articles mentioning ABT

3